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Deciphering the b-Structure Interconversion of the Alzheimer’s Amyloid-
b Peptide Along Fibrils Formation
Rabia Sarroukh, Re´gis Gasper, Emilie Cerf, Jean-Marie Ruysschaert,
Erik Goormaghtigh, Vincent Raussens.
Universite´ Libre de Bruxelles, Brussels, Belgium.
Alzheimer’s disease (AD) is the most common progressive and fatal neurologic
condition. One hallmark of this disorder is characterized by polymorphous ex-
tracellular deposits called ‘‘senile plaques’’. Amyloid- beta peptide (Ab) is the
primary component of these plaques and plays an important, but not completely
understood, role in the neurotoxicity. Ab forms different entities: monomeric,
large soluble entities collectively called oligomers and insoluble fibrils. The
mechanisms leading to accumulation of misfolded peptide and the fibrils
formation remain a matter of debate.
Two-dimensional infrared correlation analysis of Ab1-42 was used to monitor
the nature of structural transitions along the aggregation process. First, con-
certed conversions head to a decrease in helical and/or random coil structure
in favour of b-sheet content. Once b-sheet appeared, we found that Ab1-42
peptide adopted in a first stage an antiparallel b-sheet structure assigned to toxic
oligomers. The final state of aggregation displaying parallel b-sheet structure as
expected for fibrils. On IR spectra an evolution of the main band absorbance of
b-sheet structure in the Amide I spectral region (1700-1600 cm1) to higher
wavenumbers is observed. We assign this bandshift using 2-D correlation
analysis to the interconversion of oligomers into fibrils by a reorientation of
b-strands (probably by a 90 rotation) along their axes, allowing the transition
from antiparallel to parallel b-sheet.
This work addresses new point in antiparallel b-sheet structure implications in
aggregation as well as in the kinetic of fibrils formation which were so far con-
tentious. This structure seems particularly important for transient toxic interme-
diates and required for further aggregation.
[1] E. Cerf, R. Sarroukh et al. Antiparallel beta-sheet: a signature structure of
the oligomeric amyloid beta-peptide, Biochem.J. 421 (2009) 415-23.
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Nathan N. Alder, Craig E. Nelson.
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Amylin is an endocrine hormone that helps regulate blood glucose levels and
controls appetite. In patients with type 2 diabetes, amylin misfolds into amyloid
plaques that have been implicated in the destruction of the pancreatic b-cells
that synthesize insulin and amylin. The plaques found in situ contain not
only amylin but heparan sulfate proteoglycans that attach to the fibrils through
their glycosaminoglycan chains. We investigated the interaction of amylin with
heparin fragments of defined length, that model the glycosaminoglycan chains
associated with amyloid deposits. We found that heparin enhances fibrillization
in a manner that depends on the length of the polysaccharide fragments. We
used NMR to establish that the negatively charged heparin fragments bind to
the positively charged N-terminal half of amylin. We used FRET to determine
that heparin associates with amylin fibrils rather than enhancing fibrillization
catalytically. We used TIRFM to show that fluorescein-labeled heparin is co-
localized with amylin fibrils. The mechanism of binding appears to involve
electrostatic complementation between the negatively charged heparin helix
structure and the positively charged cross-b sheet structure of amylin fibrils.
To see how heparin affects the biological function of amylin, we used a fluori-
metric assay of cytotoxicity towards a mouse model of pancreatic b-cells. With
heparin fragments longer than 20 saccharides, cell death was similar to when
amylin was added alone. By contrast, short heparin fragments of 2 to 8 saccha-
rides protect against cytotoxicity and as such may be leads for drugs to treat
type 2 diabetes.
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Priyanka Narayan, Kristina A. Ganzinger, James McColl, Anna Drews,
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The devastating symptoms of Alzheimer’s disease (AD) have been attributed to
the aberrant aggregation of amyloid-b (Ab) peptides generated from proteolytic
cleavage of the transmembrane receptor, amyloid precursor protein (APP).
Oligomers of the peptides amyloid-b1-40 (Ab40) and amyloid-b1-42 (Ab42)
have been implicated in cytotoxicity and impaired cognitive function associ-
ated with AD1,2. Due to their heterogeneous nature, characterizing these olig-omers on a molecular level and understanding the mechanism by which they
induce cellular damage and death has proven to be difficult for conventional
biochemical techniques. In this work, we use two color total internal reflection
fluorescence microscopy first to characterize various preparations of Ab oligo-
mers on a molecular-level and then to explore the interactions of these well-
characterized mixtures with live cells. Among the cellular systems examined
include those expressing the prion protein receptor (PrPc) which, in recent
studies, has been suggested to have a key role in mediating the toxic effects
of Ab oligomers3. From these studies we have not only been able to gain insight
into the relationship between Ab oligomers and PrPc on live cells but also
have developed a methodology for examination of receptor-mediated Ab
neurotoxicity.
1. Chiti, F. & Dobson, C.M. Protein misfolding, functional amyloid, and human
disease. Annual Review of Biochemistry 75, 333-366 (2006).
2. Cleary, J.P. et al. Natural oligomers of the amyloid-b protein specifically
disrupt cognitive function. Nature Neuroscience 8, 79-84 (2005).
3. Lauren, J., Gimbel, D.A., Nygaard, H.B., Gilbert, J.W. & Strittmatter, S.M.
Cellular prion protein mediates impairment of synaptic plasticity by amyloid-
b oligomers. Nature 457, 1128-1132 (2009).
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Gamma synuclein (GS) is a neuronal protein that is expressed at high levels in
several cancers and disease states. Like its family member alpha-synuclein, GS
is considered to be a natively unfolded protein that can form helical oligomers.
Also like alpha-synuclein, the cellular function of GS has yet to be determined.
Here, we have characterized the oligomerization of GS using fluorescence ho-
motransfer, photon-counting histogram (PCH) analysis and native gel electro-
phoresis. We find that purified GS is monomeric on chromatographs under
denaturing conditions, but under native conditions it exists as oligomers of
varying sizes, with the tetrameric form being the most prevalent. We followed
the monomer to tetramer oligomerization by labeling the protein with FITC and
following the concentration-dependent loss in fluorescence anisotropy due to
homotransfer. PCH analysis, fluorescence correlation measurements and native
gel electrophoresis show that placement of the probe and the physical proper-
ties of the probe affect the distribution of oligomers. Addition of the enzyme
phospholipase Cb2, a strong GS binding partner whose cellular expression is
correlated with GS, results in disruption of GS tetramers and changes in the
ability of the enzyme to be activated by G proteins. We propose that one func-
tion of GS is to modulate PLCb2 activity.Awards and National Lecture
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Shedding Light on Single Molecules
Steven Block.
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Technical advances over the past few decades have led to the birth a new field,
dubbed ‘‘single molecule biophysics.’’ Single-molecule methods can record
molecular characteristics that are otherwise obscured using traditional,
ensemble-based approaches, and thereby reveal rich new behaviors in biomole-
cules of interest. An entire arsenal of techniques boasting single-molecule sen-
sitivity has already been developed, including single-channel recording,
atomic- and scanned-force microscopy, single-molecule fluorescence and
FRET (Fo¨rster resonance energy transfer), magnetic tweezers, and more. Prom-
inent among the enabling technologies has been the optical trap, or ‘‘optical
tweezers,’’ which is based on radiation pressure produced by an infrared laser.
When combined with suitable in vitro assays for function, optical trapping mi-
croscopes can measure macromolecular properties with unprecedented preci-
sion, right down the atomic level (currently achieving a resolution of 1
angstrom over a bandwidth of 100 Hz), all while exerting exquisitely controlled
forces in the piconewton (pN) range. Ultrasensitive systems for measuring force
and displacement permit the nanomechanical properties of individual biomole-
cules to be explored noninvasively. Among the more notable successes for opti-
cal traps have been measurements of the fundamental steps (and forces)
generated by motor proteins and processive nucleic acid enzymes, the strengths
of noncovalent bonds between proteins, and the kinetics and energetics of fold-
ing in biopolymers, including proteins, DNA, and RNA. This talk will celebrate
the success of optical traps in helping to establish single molecule biophysics.
